Indivior’s restructuring plan is taking shape with initial headcount reductions to help move toward a more simplified ...

China biotech RemeGen and its new U.S. partner Vor Bio are on a roll with their first-in-class autoimmune treatment ...

In the heat of the CDK4/6 market showdown, Eli Lilly has notched an overall survival win to back Verzenio’s case against ...

To check the pulse on the U.S. biopharma industry, few states are better situated than the life sciences hotspot that is ...

Phreesia is bringing Sesame Street to the doctor’s office. The patient activation company has partnered with the nonprofit ...

With the nod, Zemcelpro offers a first-of-its-kind option to many of the thousands of patients who are diagnosed each year in ...

A newly published report developed by a group of partners including Sanofi shines a light on the far-reaching impacts of well-funded community health worker (CHW) programs. | A newly published report ...

As for why ClevelandDx has chosen to re-up the “PSA on PSA” campaign for three years running rather than launching an entirely new initiative every Prostate Cancer Awareness Month, Rochelle cited both ...

For the first time, Akeso and Summit Therapeutics’ closely watched PD-1xVEGF bispecific antibody has shown that it can extend ...

Weeks after telegraphing a series of upgrades to its Mexico operations over the next five years, Bayer is rolling up its ...

The advancement of Pfizer’s antibody-drug conjugate portfolio has not spared the former Seagen site—and those who helped ...

In May, radiopharmaceutical drug developer Ratio Therapeutics unveiled plans to build a new research and manufacturing plant ...